Markets:

Overview

News

Currencies

International

Treasuries

Arrowhead Pharmaceuticals, Inc. - Common Stock (NQ:ARWR)

41.14 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Arrowhead Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On. ↗

February 23, 2024

Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.

Via Investor's Business Daily

7 Biotech Stocks Fighting America’s Deadliest Diseases ↗

February 08, 2024

Although the human condition can be alarmingly frail at times, these groundbreaking biotech stocks are aiming to right the ship.

Via InvestorPlace

Cracking The Code: Understanding Analyst Reviews For Arrowhead Pharma ↗

February 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 06, 2024

Via Benzinga

Recap: Arrowhead Pharma Q1 Earnings ↗

February 06, 2024

Via Benzinga

Earnings Scheduled For February 6, 2024 ↗

February 06, 2024

Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.

Via Benzinga

4 Analysts Assess Arrowhead Pharma: What You Need To Know ↗

January 02, 2024

Via Benzinga

What 4 Analyst Ratings Have To Say About Arrowhead Pharma ↗

December 04, 2023

Via Benzinga

Recap: Arrowhead Pharma Q4 Earnings ↗

November 29, 2023

Via Benzinga

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗

January 05, 2024

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.

Via Investor's Business Daily

Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday ↗

January 04, 2024

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following...

Via Benzinga

Topics Stocks

Why Arrowhead Pharmaceuticals Shares Are Moving ↗

January 03, 2024

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) shares are trading higher by 5.4% to $32.68, gaining after initially falling, after the company priced an underwritten registered offering of about 15.79...

Via Benzinga

Earnings Outlook For Arrowhead Pharma ↗

November 28, 2023

Via Benzinga

Analyst Expectations for Arrowhead Pharma's Future ↗

September 19, 2023

Via Benzinga

Analyst Ratings for Arrowhead Pharma ↗

August 08, 2023

Via Benzinga

Analyst Expectations for Arrowhead Pharma's Future ↗

July 21, 2023

Via Benzinga

Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 03, 2024

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock.

Via Benzinga

TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗

January 03, 2024

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a...

Via Benzinga

Topics Stocks

Expert Ratings for Arrowhead Pharma ↗

June 30, 2023

Via Benzinga

Where Arrowhead Pharma Stands With Analysts ↗

May 24, 2023

Via Benzinga

Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback ↗

December 29, 2023

Piper Sandler sees potential turnaround for Biotech sector in 2024, identifies thee top stocks; Arrowhead, Legend Biotech & Alnylam Pharmaceuticals.

Via Benzinga

Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

November 30, 2023

Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.

Via Benzinga

Earnings Scheduled For November 29, 2023 ↗

November 29, 2023

Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per share on revenue of $3.50 million.

Via Benzinga

Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK ↗

October 31, 2023

GSK plc (NYSE: GSK) and Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) have

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023 ↗

September 19, 2023

Via Benzinga

Cramer Says 'Please Stay Away' From This EV Maker, It 'Should Not Be Public' ↗

September 08, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Norfolk Southern Corporation (NYSE: NSC) is the "cheapest I’ve seen in a very long time,

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023 ↗

July 21, 2023

Via Benzinga

Eli Lilly Just Lent Its Big Pharma Cachet To Verve's Nascent Gene-Editing Program For $60 Million ↗

June 15, 2023

Eli Lilly inked a deal worth $60 million to get in on a gene-editing drug for elevated lipoprotein A.

Via Investor's Business Daily

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree ↗

June 02, 2023

Big Pharma is facing a patent cliff that could siphon off billions in revenue.

Via Investor's Business Daily

Arrowhead CEO Christopher Anzalone Addresses The 'Really Important Event' In Lung Disease ↗

June 01, 2023

Arrowhead CEO Christopher Anzalone discusses expectations for ARO-RAGE in lung disease.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.